What initial guidance ONE Gas OGS ONE Gas posts 14 EPS miss vs analyst estimates Moderna Inc MRNA Counterparty Arbutus Biopharma Secures Regulatory Catalyst Amid Settled LNP Licensing Agreement DLO DLocal posts narrow Q4 2025 EPS beat shares gain 338 percent after earnings release NOW Inc PSENOW Valuation Assessment Amid Mixed Price Volatility and Consistent Overvaluation Signals Alnylam Pharmaceuticals Inc ALNY Phase 2 Diabetes Drug Progress and SP 500 Contender Status Lift Bullish Outlook EHLD Euroholdings CEO signals positive longterm demand outlook plans targeted investments in highgrowth regional markets FBRT Franklin posts 577 percent Q4 2025 EPS miss trades slightly higher despite weaker than expected results